Kyle Jenne
CIK 1791857 · EVP, Chf GL Pdt Str Ofcr · last filed 2026-04-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.10M
Companies
2
Total Filings
13
Lifetime Open-Market Net
-$3.44M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IONS | EVP, Chf GL Pdt Str Ofcr | 28,615 | $73.28 | $2.10M | -$3.42M | 8 | 2026-04-17 |
| AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Chief Commercial Officer | 0 | — | — | -$22.2K | 5 | 2020-10-13 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-03-25 | AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Sell (S) | −779 | -$9.2K | EDGAR |
| 2020-03-23 | AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Grant (A) | +16,800 | $0 | EDGAR |
| 2019-10-23 | AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.